Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models
抗 CD160 单独使用或与贝伐单抗联合使用，是兔和猴模型中眼部新生血管的强效抑制剂
期刊:Investigative Ophthalmology & Visual Science
影响因子:5
doi:10.1167/iovs.18-24024
Thierry Menguy, Anne Briaux, Elisabeth Jeunesse, Jérôme Giustiniani, Alexandre Calcei, Thierry Guyon, Jacques Mizrahi, Hélène Haegel, Vanessa Duong, Vincent Soler, Pierre Brousset, Armand Bensussan, Isabelle Raymond Letron, Philippe Le Bouteiller
